You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
  1. CORPORATE - 29-09-2015

    Kedrion Notes 2019 Tender Offer results

    Kedrion has accepted for purchase Notes validly tendered for a total aggregate principal amount equal to €150,716,000

    read more 
  2. CORPORATE - 21-09-2015

    Cash Tender Offer for Notes due 24 April 2019

    Kedrion S.p.A. announced Cash Tender Offer for its €300,000,000 4.625 per cent. outstanding Notes due 24 April 2019

    read more 
  3. CORPORATE - 20-07-2015

    KEDPlasma welcomes donors to its new Augsburg collection center

    Plasma collected in Germany is essential to Kedrion Biopharma’s plasma-derived therapies

    read more 
  4. EVENTS - 13-07-2015

    Revolutionary PID testing from Tuscany, Italy

    Kedrion at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies

    read more 

Pages

For more information please contact: pressoffice@kedrion.com